Luca Issi
Stock Analyst at RBC Capital
(2.42)
# 2,500
Out of 4,984 analysts
204
Total ratings
47.2%
Success rate
-1.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $70 → $80 | $61.17 | +30.78% | 9 | Sep 4, 2025 | |
| ARGX argenx SE | Initiates: Outperform | $850 | $734.35 | +15.75% | 1 | Aug 25, 2025 | |
| RGNX REGENXBIO | Maintains: Outperform | $21 → $17 | $9.03 | +88.26% | 10 | Aug 8, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Outperform | $25 → $21 | $12.41 | +69.22% | 5 | Aug 8, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $40 → $38 | $29.13 | +30.45% | 9 | Aug 8, 2025 | |
| ASND Ascendis Pharma | Maintains: Outperform | $210 → $230 | $199.59 | +15.24% | 3 | Aug 8, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Sector Perform | $38 → $42 | $59.07 | -28.90% | 14 | Aug 5, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Sector Perform | $4 → $5 | $7.32 | -31.69% | 1 | Jul 30, 2025 | |
| DYN Dyne Therapeutics | Maintains: Outperform | $25 → $23 | $13.15 | +74.90% | 3 | Jul 29, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Sector Perform | $5 → $4 | $2.88 | +38.89% | 8 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.13 | +784.96% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $23.13 | -22.18% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $32 → $28 | $25.00 | +12.00% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $5.36 | +273.13% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $330 | $451.73 | -26.95% | 27 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $95 | $30.38 | +212.71% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.51 | +290.09% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $12.17 | +39.75% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $7.33 | +77.35% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $6.66 | +425.53% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $22.45 | +15.81% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $54.37 | +28.75% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $24 | $14.16 | +69.49% | 6 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $34.79 | +63.84% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $67 | $40.06 | +67.25% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $2.72 | +47.06% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $28.71 | +168.20% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $15 | $6.80 | +120.59% | 5 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.72 | +713.95% | 5 | Aug 7, 2024 |
Ionis Pharmaceuticals
Sep 4, 2025
Maintains: Outperform
Price Target: $70 → $80
Current: $61.17
Upside: +30.78%
argenx SE
Aug 25, 2025
Initiates: Outperform
Price Target: $850
Current: $734.35
Upside: +15.75%
REGENXBIO
Aug 8, 2025
Maintains: Outperform
Price Target: $21 → $17
Current: $9.03
Upside: +88.26%
Intellia Therapeutics
Aug 8, 2025
Maintains: Outperform
Price Target: $25 → $21
Current: $12.41
Upside: +69.22%
Arrowhead Pharmaceuticals
Aug 8, 2025
Maintains: Outperform
Price Target: $40 → $38
Current: $29.13
Upside: +30.45%
Ascendis Pharma
Aug 8, 2025
Maintains: Outperform
Price Target: $210 → $230
Current: $199.59
Upside: +15.24%
CRISPR Therapeutics AG
Aug 5, 2025
Maintains: Sector Perform
Price Target: $38 → $42
Current: $59.07
Upside: -28.90%
Fulcrum Therapeutics
Jul 30, 2025
Maintains: Sector Perform
Price Target: $4 → $5
Current: $7.32
Upside: -31.69%
Dyne Therapeutics
Jul 29, 2025
Maintains: Outperform
Price Target: $25 → $23
Current: $13.15
Upside: +74.90%
Adverum Biotechnologies
May 15, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.88
Upside: +38.89%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.13
Upside: +784.96%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $23.13
Upside: -22.18%
May 2, 2025
Maintains: Sector Perform
Price Target: $32 → $28
Current: $25.00
Upside: +12.00%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $5.36
Upside: +273.13%
Mar 21, 2025
Maintains: Outperform
Price Target: $310 → $330
Current: $451.73
Upside: -26.95%
Mar 19, 2025
Maintains: Outperform
Price Target: $105 → $95
Current: $30.38
Upside: +212.71%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.51
Upside: +290.09%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $12.17
Upside: +39.75%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $7.33
Upside: +77.35%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $6.66
Upside: +425.53%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $22.45
Upside: +15.81%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $54.37
Upside: +28.75%
Jan 21, 2025
Reiterates: Outperform
Price Target: $24
Current: $14.16
Upside: +69.49%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $34.79
Upside: +63.84%
Jan 21, 2025
Reiterates: Outperform
Price Target: $67
Current: $40.06
Upside: +67.25%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.72
Upside: +47.06%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $28.71
Upside: +168.20%
Oct 21, 2024
Maintains: Sector Perform
Price Target: $7 → $15
Current: $6.80
Upside: +120.59%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.72
Upside: +713.95%